V7A0 Stock Overview
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
The Beauty Health Company Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$3.94 |
52 Week High | US$12.50 |
52 Week Low | US$1.36 |
Beta | 0.95 |
1 Month Change | 47.01% |
3 Month Change | 34.01% |
1 Year Change | -64.66% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -60.77% |
Recent News & Updates
Recent updates
Shareholder Returns
V7A0 | DE Personal Products | DE Market | |
---|---|---|---|
7D | 18.7% | 0.3% | 1.3% |
1Y | -64.7% | 3.2% | 6.4% |
Return vs Industry: V7A0 underperformed the German Personal Products industry which returned 3.8% over the past year.
Return vs Market: V7A0 underperformed the German Market which returned 7.5% over the past year.
Price Volatility
V7A0 volatility | |
---|---|
V7A0 Average Weekly Movement | 13.4% |
Personal Products Industry Average Movement | 4.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: V7A0's share price has been volatile over the past 3 months.
Volatility Over Time: V7A0's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 881 | Marla Beck | https://www.beautyhealth.com |
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company’s flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer’s preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.
The Beauty Health Company Fundamentals Summary
V7A0 fundamental statistics | |
---|---|
Market cap | €490.00m |
Earnings (TTM) | -€92.65m |
Revenue (TTM) | €368.30m |
1.3x
P/S Ratio-5.3x
P/E RatioIs V7A0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
V7A0 income statement (TTM) | |
---|---|
Revenue | US$397.99m |
Cost of Revenue | US$242.88m |
Gross Profit | US$155.11m |
Other Expenses | US$255.23m |
Earnings | -US$100.12m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.81 |
Gross Margin | 38.97% |
Net Profit Margin | -25.16% |
Debt/Equity Ratio | 1,243.3% |
How did V7A0 perform over the long term?
See historical performance and comparison